In this issue, highlights from the Irish Nephrology Society and European Association of Urology 2024 Annual...

Neoadjuvant immunotherapy given for stage III melanoma, followed by adjuvant therapy only if there is not...

Osimertinib improves PFS in patients with unresectable stage III EGFR-mutated non-small cell lung cancer (NSCLC)...

The antibody-drug conjugate trastuzumab deruxtecan delays cancer growth for women with hormone receptor-positive (HR+)...

According to a new study presented at the 2024 ASCO Annual Meeting, adding the antibody-drug conjugate...

For patients with locally advanced oesophageal adenocarcinoma that can be treated with surgery, chemotherapy treatment...

Results from a new study presented at the 2024 American Society of Clinical Oncology (ASCO) Annual...

The management of bladder cancer is evolving rapidly, with a new regimen recently approved for patients...

Interferon seems to raise migraine risk in people with MS, while rituximab may lower it. A...

The American Headache Society recently issued a position statement update on the use of migraine prevention...

An overview of the latest insights, diagnostic criteria, and treatment approaches for migraines. Migraine is the...

In this issue, highlights from Irish Society for Rheumatology Spring Meeting 2024, guidance and...